These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2725294)

  • 1. Induction of profound hypouricemia by a non-sedating thiobarbiturate.
    Warrell RP; Muindi J; Stevens YW; Isaacs M; Young CW
    Metabolism; 1989 Jun; 38(6):550-4. PubMed ID: 2725294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro differential metabolism of merbarone by xanthine oxidase and microsomal flavoenzymes. The role of reactive oxygen species.
    Muindi JF; Stevens YW; Warrell RP; Young CW
    Drug Metab Dispos; 1993; 21(3):410-4. PubMed ID: 8100495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure.
    Andreoli SP; Clark JH; McGuire WA; Bergstein JM
    J Pediatr; 1986 Aug; 109(2):292-8. PubMed ID: 3461147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postchemotherapy purine excretion in lymphoma patients receiving allopurinol.
    Hande KR; Hixson CV; Chabner BA
    Cancer Res; 1981 Jun; 41(6):2273-9. PubMed ID: 7237428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of uric acid and oxypurines in normal subjects and in gout patients].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of hypoxanthine and xanthine in normal subjects and in four cases of idiopathic renal hypouricemia.
    Kaneko K; Fujimori S; Itoh H; Nakayama Y; Oyama H; Kanbayashi T; Miyashita H; Akaoka I
    J Rheumatol; 1988 Feb; 15(2):325-30. PubMed ID: 3361540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos TH
    Am J Med; 1988 Oct; 85(4):533-7. PubMed ID: 3177401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical and pharmacological study of merbarone.
    Dimaggio JJ; Warrell RP; Muindi J; Stevens YW; Lee SJ; Lowenthal DA; Haines I; Walsh TD; Baltzer L; Yaldaei S
    Cancer Res; 1990 Feb; 50(4):1151-5. PubMed ID: 2297763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probenecid on oxypurines in plasma.
    Yamamoto T; Takahashi S; Suda M; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):510-4. PubMed ID: 2511159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased xanthine oxidase activities and increased urinary oxypurines in heterozygotes for hereditary xanthinuria.
    Kawachi M; Kono N; Mineo I; Yamada Y; Tarui S
    Clin Chim Acta; 1990 Apr; 188(2):137-46. PubMed ID: 2379312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of oxypurines and uric acid in plasma, renal excretion of oxypurines and uric acid as well as plasma adenosine deaminase and AMP deaminase activity in patients with essential hypertension].
    Tykarski A; Głuszek J; Banaszak F
    Pol Arch Med Wewn; 1993 Mar; 89(3):223-9. PubMed ID: 8327372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolites in congenital hyperuricosuria.
    Balis ME; Krakoff IH; Berman PH; Dancis J
    Science; 1967 May; 156(3778):1122-3. PubMed ID: 6024192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hypouricemia associated with hyperoxypurinemia due to decreased renal excretion of oxypurines: a new defect in renal purine transport.
    Kawachi M; Kono N; Mineo I; Kiyokawa H; Nakajima H; Shimizu T; Ono A; Nishimura T; Yorifuji S; Kuwajima M
    Adv Exp Med Biol; 1991; 309A():239-42. PubMed ID: 1789216
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of xanthinuria: a study on the metabolism of pyrazinamide and allopurinol.
    Yamamoto T; Kario K; Suda M; Moriwaki Y; Takahashi S; Higashino K
    Jpn J Med; 1991; 30(5):430-4. PubMed ID: 1803043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine metabolism in women with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
    Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
    Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
    Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.
    Komoriya K; Osada Y; Hasegawa M; Horiuchi H; Kondo S; Couch RC; Griffin TB
    Eur J Pharmacol; 1993 Dec; 250(3):455-60. PubMed ID: 8112406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.